United States · FDA National Drug Code directory
CEREBYX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-6001_c2767f24-e5ac-4d94-8bff-faf0a6eaf7c4
- Product NDC
- 0069-6001
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Fosphenytoin Sodium
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20131028
- Source listing expiry
- 20261231
Source-listed ingredients
- FOSPHENYTOIN SODIUM — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 PACKAGE (0069-6001-21) / 10 mL in 1 VIAL (0069-6001-10) · 0069-6001-21
- 25 VIAL in 1 CARTON (0069-6001-25) / 2 mL in 1 VIAL (0069-6001-02) · 0069-6001-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →